Serum tumor markers such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19‐9 (CA19‐9) have been investigated as predictors of chemotherapy response, but it is not clear whether changes in these markers can predict the efficacy of chemotherapy on the primary tumor [9]. Here, CEACAM5 is linked to neoplasm.